GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hypha Labs Inc (OTCPK:DIGP) » Definitions » Other Net Income (Loss)

Hypha Labs (Hypha Labs) Other Net Income (Loss) : $1.22 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Hypha Labs Other Net Income (Loss)?

Hypha Labs's Other Net Income (Loss) for the three months ended in Dec. 2023 was $0.29 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.22 Mil.

Hypha Labs's quarterly Other Net Income (Loss) declined from Jun. 2023 ($0.45 Mil) to Sep. 2023 ($0.43 Mil) and declined from Sep. 2023 ($0.43 Mil) to Dec. 2023 ($0.29 Mil).

Hypha Labs's annual Other Net Income (Loss) increased from Sep. 2021 ($0.00 Mil) to Sep. 2022 ($0.12 Mil) and increased from Sep. 2022 ($0.12 Mil) to Sep. 2023 ($0.93 Mil).


Hypha Labs Other Net Income (Loss) Historical Data

The historical data trend for Hypha Labs's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypha Labs Other Net Income (Loss) Chart

Hypha Labs Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.12 0.93

Hypha Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.06 0.45 0.43 0.29

Hypha Labs Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypha Labs Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Hypha Labs's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypha Labs (Hypha Labs) Business Description

Traded in Other Exchanges
N/A
Address
6450 Cameron Street, Suite 113, Las Vegas, NV, USA, 89118
DigiPath Inc is engaged in providing pharmaceutical-grade analysis and testing cannabis education and training and brings unbiased cannabis news coverage to the cannabis industry. It screens medicinal cannabis for potentially harmful contaminants, including solvents, pesticides, mold and yeast, heavy metals such as mercury, arsenic, cadmium, and others. It also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.
Executives
A Stone Douglass director 10200 WILLOW CREEK ROAD, SAN DIEGO CA 92131
Edmond Defrank director 19360 RINALDI STREET, #448, NORTHRIDGE CA 91326
Kyle Remenda officer: Chief Executive Officer 111-2532 SHORELINE DRIVE, LAKE COUNTRY A1 V4V2R6
Dennis Hartmann director 1600 CAMDEN AVENUE, NO. 103, LOS ANGELES CA 90025
Bruce I Raben director 430 VICTORIA TERRACE, RIDGEFIELD NJ 7657
Cindy Sue Orser director 4507 APPLE WAY, BOULDER CO 80301
Alfredo Axtmayer director 287 PAYNE DRIVE, CHESHIRE CT 06410
Joseph J Bianco director 611 BROADWAY,, SUITE 307, NEW YORK NY 10012
Todd A Peterson officer: Chief Financial Officer 3608 MALLARDWOOD DRIVE, LAS VEGAS NV 89129
Joe D Tanner director 28720 ROADSIDE DRIVE, SUITE 128, AGOURA HILLS CA 91301
Raw Alternative, Llc 10 percent owner 16030 VENTURA BLVD. SUITE 380, ENCINO CA 91436
Todd Denkin director, officer: President C/O PHOTOTRON, INC., 20259 VENTURA BLVD., WOODLAND HILLS CA 91364
Barbee Denny Barbee 10 percent owner 3105 EAST CENTRAL, #114, WICHITA KS 67214
Eric Stoppenhagen director, 10 percent owner, officer: CFO 8908 SPLITARROW DRIVE, AUSTIN TX 78717

Hypha Labs (Hypha Labs) Headlines

From GuruFocus

Digipath Completes Acquisition of VSSL Enterprises Ltd.

By Marketwired Marketwired 03-16-2020

Digipath Processes Record Number of Samples, Plans Expansion

By Marketwired Marketwired 02-04-2020

Todd Denkin to Return to the Digipath Helm

By Marketwired Marketwired 07-08-2021

Digipath Announces Results for Third Fiscal Quarter 2020

By Marketwired Marketwired 08-17-2020

Stone Douglass Joins Digipath's Board of Directors

By Marketwired Marketwired 07-07-2021

Digipath Announces Financial Results for Q1, 2022

By GuruFocusNews GuruFocusNews 02-15-2022

Digipath Announces Results for Second Fiscal Quarter 2021

By Marketwired Marketwired 05-18-2021